Annual report
4503.TEDINET S100VXR3
Period2024-04-01 → 2025-03-31
Filed2025-06-16
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 157
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.91T | 2024-04-01 → 2025-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥1.60T | 2023-04-01 → 2024-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥1.52T | 2022-04-01 → 2023-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.30T | 2021-04-01 → 2022-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.25T | 2020-04-01 → 2021-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥41.0bn | 2024-04-01 → 2025-03-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥25.5bn | 2023-04-01 → 2024-03-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥31.2bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥25.0bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥132.4bn | 2022-04-01 → 2023-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥156.9bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥145.3bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | ¥50.7bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥17.0bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥98.7bn | 2022-04-01 → 2023-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥124.1bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥120.6bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | ¥50.7bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥17.0bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss IFRS |
| Total assets | ¥3.34T | at 2025-03-31 | Cons. | Assets IFRS |
| Total assets | ¥3.57T | at 2024-03-31 | Cons. | Assets IFRS |
| Total assets | ¥2.46T | at 2023-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥2.33T | at 2022-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥2.27T | at 2021-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥1.83T | at 2025-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥1.97T | at 2024-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥1.51T | at 2025-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.60T | at 2024-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.51T | at 2023-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥1.51T | at 2025-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.60T | at 2024-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.51T | at 2023-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥1.46T | at 2022-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥1.39T | at 2021-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥188.4bn | at 2025-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥335.7bn | at 2024-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥376.8bn | at 2023-03-31d | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥316.0bn | at 2022-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥326.1bn | at 2021-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥194.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥172.5bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥327.8bn | 2022-04-01 → 2023-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥257.4bn | 2021-04-01 → 2022-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥306.8bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | −¥89.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥845.8bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥84.5bn | 2022-04-01 → 2023-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥62.4bn | 2021-04-01 → 2022-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥81.9bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | −¥261.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥614.1bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥195.6bn | 2022-04-01 → 2023-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥216.3bn | 2021-04-01 → 2022-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥229.5bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥28.35 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥9.51 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥54.24 | 2022-04-01 → 2023-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥67.08 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥64.93 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥28.24 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥9.47 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥54.09 | 2022-04-01 → 2023-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥67.05 | 2021-04-01 → 2022-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥64.9 | 2020-04-01 → 2021-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥845.25 | at 2025-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥890.07 | at 2024-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥839.26 | at 2023-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥799.26 | at 2022-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥748.03 | at 2021-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 45.3% | at 2025-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 44.7% | at 2024-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 61.4% | at 2023-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 62.6% | at 2022-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 61.0% | at 2021-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 3.3% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 1.1% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 6.7% | 2022-04-01 → 2023-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 8.7% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 9.0% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 13,643 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 14,754 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 14,484 | at 2023-03-31d | Cons. | Number of employees |
| Employees | 14,522 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 15,455 | at 2021-03-31d | Cons. | Number of employees |
| Revenue | ¥789.6bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥688.4bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥613.6bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥542.6bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥545.6bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥267.3bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | ¥194.0bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥431.1bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥373.3bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥338.2bn | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥270.5bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥223.4bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥362.2bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥333.1bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥319.7bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥292.2bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥314.2bn | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥225.1bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥193.1bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥2.56T | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥2.46T | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥1.49T | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.39T | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.35T | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.19T | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥1.28T | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.37T | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.18T | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.02T | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥873.6bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥787.7bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥46.6bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥153.1bn | at 2024-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥178.59 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥162.92 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥172.64 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥121.69 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥103.95 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥178.55 | 2024-04-01 → 2025-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥162.87 | 2023-04-01 → 2024-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥172.57 | 2022-04-01 → 2023-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥121.63 | 2021-04-01 → 2022-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥103.89 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥74 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥70 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2022-04-01 → 2023-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥42 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥763.31 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥660 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥568.97 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥477.81 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥424.69 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 53.4% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.1% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.7% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.9% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.3% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 25.1% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 26.5% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 33.2% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 27.1% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 26.5% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 1,809,663,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,809,663,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,809,663,000 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,835,852,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,861,787,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 4,105 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 4,806 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 4,867 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 3,943 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 4,647 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 2
| Segment | Item | Period | Value |
|---|---|---|---|
| Pharmaceuticalreportable segment | employees | at 2025-03-31 | 13643 pure |
| Pharmaceuticalreportable segment | employees | at 2025-03-31 | 4105 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,746
| Item | Context | Value | Unit |
|---|---|---|---|
| Change in fair value of contingent considerations income IFRS | Prior1YearDuration | 2636000000 | JPY |
| Change in fair value of contingent considerations income IFRS | CurrentYearDuration | 16672000000 | JPY |
| Other other income IFRS | Prior1YearDuration | 6055000000 | JPY |
| Other other income IFRS | CurrentYearDuration | 3672000000 | JPY |
| Other income IFRS | Prior1YearDuration | 8691000000 | JPY |
| Other income IFRS | CurrentYearDuration | 20344000000 | JPY |
| Impairment losses for goodwill other expenses IFRS | Prior1YearDuration | 15105000000 | JPY |
| Inpairment losses for property plant and equipment other expenses IFRS | CurrentYearDuration | － | JPY |
| Impairment losses for intangible asssets other expenses IFRS | Prior1YearDuration | 63826000000 | JPY |
| Impairment losses for intangible asssets other expenses IFRS | CurrentYearDuration | 187618000000 | JPY |
| Change in fair value of contingent considerations IFRS | Prior1YearDuration | 24667000000 | JPY |
| Change in fair value of contingent considerations IFRS | CurrentYearDuration | － | JPY |
| Restructuring expenses IFRS | Prior1YearDuration | 25407000000 | JPY |
| Restructuring expenses IFRS | CurrentYearDuration | 15523000000 | JPY |
| Loss on litigation IFRS | Prior1YearDuration | 514000000 | JPY |
| Loss on litigation IFRS | CurrentYearDuration | 1573000000 | JPY |
| Foreign exchange loss IFRS | Prior1YearDuration | 807000000 | JPY |
| Foreign exchange loss IFRS | CurrentYearDuration | 18578000000 | JPY |
| Replacement awards with business combination IFRS | Prior1YearDuration | 33434000000 | JPY |
| Replacement awards with business combination IFRS | CurrentYearDuration | － | JPY |
| Other other expenses IFRS | Prior1YearDuration | 4054000000 | JPY |
| Other other expenses IFRS | CurrentYearDuration | 12475000000 | JPY |
| Other expenses IFRS | Prior1YearDuration | 167814000000 | JPY |
| Other expenses IFRS | CurrentYearDuration | 235768000000 | JPY |
| Interest income IFRS | Prior1YearDuration | 8772000000 | JPY |
| Interest income IFRS | CurrentYearDuration | 6839000000 | JPY |
| Dividend income IFRS | Prior1YearDuration | 79000000 | JPY |
| Dividend income IFRS | CurrentYearDuration | 46000000 | JPY |
| Gain on valuation of investments in funds IFRS | Prior1YearDuration | 2384000000 | JPY |
| Gain on valuation of investments in funds IFRS | CurrentYearDuration | 812000000 | JPY |
| Other finance income IFRS | Prior1YearDuration | 220000000 | JPY |
| Other finance income IFRS | CurrentYearDuration | 177000000 | JPY |
| Finance income IFRS | Prior1YearDuration | 11455000000 | JPY |
| Finance income IFRS | CurrentYearDuration | 7874000000 | JPY |
| Interest expenses IFRS | Prior1YearDuration | 7423000000 | JPY |
| Interest expenses IFRS | CurrentYearDuration | 13952000000 | JPY |
| Loss on valuation of investments in funds IFRS | Prior1YearDuration | 2637000000 | JPY |
| Loss on valuation of investments in funds IFRS | CurrentYearDuration | 3328000000 | JPY |
| Other finance costs IFRS | Prior1YearDuration | 1945000000 | JPY |
| Other finance costs IFRS | CurrentYearDuration | 397000000 | JPY |
| Finance costs IFRS | Prior1YearDuration | 12005000000 | JPY |
| Finance costs IFRS | CurrentYearDuration | 17677000000 | JPY |
| Buildings and structures acquisition cost IFRS | Prior1YearInstant | 275304000000 | JPY |
| Machinery and vehicles acquisition cost IFRS | Prior1YearInstant | 144558000000 | JPY |
| Tools furniture and fixtures acquisition cost IFRS | Prior1YearInstant | 118381000000 | JPY |
| Land acquisition cost IFRS | Prior1YearInstant | 18865000000 | JPY |
| Construction in progress acquisition cost IFRS | Prior1YearInstant | 15699000000 | JPY |
| Right of use assets acquisition cost IFRS | Prior1YearInstant | 116671000000 | JPY |
| Property plant and equipment acquisition cost IFRS | Prior1YearInstant | 689479000000 | JPY |
| Buildings and structures accumulated depreciation and impairment losses IFRS | Prior1YearInstant | -137072000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 21 of 21 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |